Products

SOMNUM
HoneyNaps
Clinical Decision Support & Reference
SOMNUM is an AI-enabled medical software tool by Honeynaps Co., Ltd. that provides comprehensive sleep analysis to aid in the diagnosis and management of sleep disorders.

See all 1 product →

About Honeynaps Co.

Honeynaps Co. is a South Korean digital health company specializing in AI-driven sleep diagnostics, sleep disorder analytics, and next-generation sleep healthcare solutions. The company develops technologies that enhance access, efficiency, and clinical accuracy in sleep medicine through artificial intelligence and scalable healthcare platforms. Their flagship product, SOMNUM, is an AI-powered software that analyzes polysomnography (PSG) data to identify sleep stages and key events like apnea, hypopnea, and arousals, providing rapid sleep disorder diagnoses within minutes. SOMNUM has received U.S.0) expanding capabilities for automated analysis and classification of sleep-disordered breathing into Obstructive, Central, and Mixed Sleep Apnea.

For physicians, Honeynaps’ technology offers a significant advancement in sleep medicine by automating and accelerating the diagnostic process, which traditionally requires manual review taking several hours per case. SOMNUM’s deep learning-based AI analyzes large volumes of multi-channel/time series biosignals in real-time, aiming for high accuracy and transparency. The company is also developing next-generation AI technologies and digital biomarkers, including Hypoxic Burden (HB), Arousal Burden (AB), and Ventilatory Burden (VB), to enable more comprehensive evaluation of disease severity and associated health risks. Beyond sleep disorder diagnosis, Honeynaps plans to expand its AI applications to other critical areas such as cardiovascular disease, dementia, and Parkinson’s disease.

Focus Areas

AI-driven sleep diagnostics sleep disorder analytics digital sleep medicine bio-signal monitoring disease prediction algorithms digital therapeutics

Business Intelligence

TechnologyDeep learning-based AI, real-time analysis of multi-channel/time series biosignals, eXplainable Medical AI (XAI) technology, cloud-native platform

What Physicians Need to Know

AI-driven Sleep Diagnostics (SOMNUMu2122)
Honeynaps' flagship product, SOMNUMu2122, is an FDA-cleared AI-based software that automates the analysis of polysomnography (PSG) data. It identifies sleep stages and key events like apnea, hypopnea, and arousals, significantly reducing manual scoring time from hours to minutes. SOMNUM V3.0 further expands capabilities for automated analysis and classification of obstructive, central, and mixed sleep apnea with over 97% agreement rates. It utilizes deep learning-based AI for real-time analysis of multi-channel, time-series biosignal data.
Sleep Disorder Analytics
The company provides advanced analytics for sleep disorders, moving beyond traditional composite indices to offer event-level classification for more accurate assessment of sleep-disordered breathing severity. Their platform supports objective, reproducible, and consistent sleep analysis across multiple study sites, aligning with American Academy of Sleep Medicine (AASM) guidelines.
Digital Sleep Medicine (SOMNUM Medella)
Honeynaps offers SOMNUM Medella, a second-generation digital therapeutic for insomnia. This solution leverages their proprietary contactless sleep data monitoring system, 'SOMNUM Scanning,' to create personalized treatment modules for insomnia, aiming to maximize patient compliance and treatment outcomes.
Bio-signal Monitoring
Honeynaps has developed an intelligent bio-signals monitoring platform, HoneyCube, which aims to collect and analyze bio-signals 24 hours a day. This includes data such as body temperature, heart rate, breathing, and movement during sleep to detect abnormal symptoms early. They are also developing a next-generation wireless polysomnography system using patch-based skin sensors to capture comprehensive physiological signals without cables.
Disease Prediction Algorithms
Beyond diagnosis, Honeynaps is developing algorithms to predict diseases using collected bio-signal data, with the goal of enabling preventive measures, customized diets, and early intervention. This includes the potential to detect or predict cardiovascular, neurological, and muscular diseases.
Digital Therapeutics
Honeynaps is actively involved in digital therapeutics, particularly for insomnia with SOMNUM Medella. These are software medical devices (SaMDs) designed to prevent, manage, or treat disorders, often based on cognitive-behavioral treatments.
Physician Tip

Honeynaps' solutions, particularly SOMNUMu2122, offer physicians a significant advantage by automating and accelerating the analysis of complex PSG data, reducing scoring time from several hours to mere minutes. The FDA clearance of SOMNUMu2122 (including V3.0 for sleep-disordered breathing classification) provides regulatory validation and assurance of the AI algorithm's clinical performance and reliability. The platform's ability to provide event-level classification and distinguish different apnea subtypes can lead to more accurate assessments and tailored treatment plans. Furthermore, their development of a wireless PSG system and contactless monitoring aims to improve patient comfort and enable broader use in both hospital and home settings. The company's focus on explainable AI (XAI) in SOMNUMu2122 enhances transparency and reliability, which can be crucial for physician trust and understanding of AI-driven diagnoses. Their expansion into CRO services also means they can support clinical trials for a wider range of therapeutic areas where sleep is a critical biomarker.

Honeynaps' SOMNUMu2122 Cloud offers a HIPAA-compliant, web-based platform for large-scale sleep data analysis, allowing users to upload EDF files from PSG devices for automated AI analysis and report generation without software installation. The company is also developing encoding/decoding software that supports international standard interfaces like HL7, DICOM, and ISO to ensure information compatibility with other medical fields. They are actively pursuing collaborations with leading US hospitals and sleep centers, and engaging in joint research and clinical partnerships with global pharmaceutical and medical device companies.

Products by Honeynaps Co.

1 product in the directory

SOMNUM
HoneyNaps
Clinical Decision Support & Reference
SOMNUM is an AI-enabled medical software tool by Honeynaps Co., Ltd. that provides comprehensive sleep analysis to aid in the diagnosis and management of sleep disorders.

Videos

News, demos, and interviews about Honeynaps Co..

Loading videos...

Videos load interactively. If none appear, search YouTube for Honeynaps Co. →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Honeynaps Co. utilizes advanced AI algorithms to analyze bio-signals for comprehensive sleep diagnostics, identifying various sleep disorders with high accuracy. Our solutions are designed for seamless integration with current Electronic Health Record (EHR) systems and clinical platforms, providing actionable insights directly to physicians and healthcare administrators.
Our platform leverages machine learning to analyze sleep patterns and bio-signals, identifying early indicators of potential health issues beyond traditional sleep disorders. This enables proactive disease prediction and facilitates the development of personalized digital therapeutic interventions tailored to individual patient needs, improving overall health outcomes.
Honeynaps Co. offers a suite of digital therapeutics focused on various sleep disorders, including CBT-I programs and personalized sleep hygiene interventions. Our products are backed by clinical trials demonstrating significant improvements in sleep quality and patient compliance, with ongoing research to further validate their long-term efficacy.
Our pricing models are flexible, offering subscription-based services and per-patient licensing options to accommodate diverse healthcare settings. We provide comprehensive technical support, including 24/7 assistance and dedicated account managers, along with extensive training programs for healthcare providers to ensure optimal utilization of our platforms.
Honeynaps Co. prioritizes data security and patient privacy, adhering to stringent regulatory standards such as HIPAA and GDPR. We employ robust encryption protocols, secure data storage, and anonymization techniques to protect sensitive patient information throughout our bio-signal monitoring and analytics processes.
Honeynaps Co. has established strategic partnerships with leading academic medical centers and research institutions to advance sleep science and digital health. We are a well-funded and rapidly growing company with a clear vision to revolutionize sleep medicine through AI, continuously innovating to provide cutting-edge solutions for improved patient care.

Related Companies

Cymetica Biosciences, operating under the brand Biomiv, develops AI systems to create proprietary algorithms aimed at optimizing human health outcomes in real-time. Their work is rooted in research from human space flight, also known as ‘space biosciences,’ and biological language modeling. The company’s AI models construct proprietary vector embeddings to fine-tune AI, enabling the extraction […]

GPnotebook is a comprehensive clinical information and educational reference tool designed for healthcare professionals, particularly general practitioners. Established in 2001, it serves as a go-to resource for primary care professionals seeking quick answers to clinical questions during consultations. The platform features over 30,000 concise, evidence-based clinical reference articles, each focused on a specific primary care […]

LabSense AI (labsense.ai) is an AI-powered medical lab result interpreter designed to democratize medical literacy globally. The platform aims to help patients understand their lab results in plain language, regardless of their education level or location. It processes lab reports (PDF or photo uploads) and provides explanations for over 86 lab tests, including blood count, […]

Intelligent Medical Objects (IMO) Health is an AI-native clinical data intelligence company that provides a foundation for modern health tech use cases. They specialize in transforming fragmented clinical documentation into structured, contextualized data, which is essential for fueling AI models, accelerating workflows, and delivering measurable outcomes across various healthcare sectors including health systems, life sciences, […]

Cloudphysician is a health-tech company that provides AI-powered solutions to transform patient care and safety in intensive care units (ICUs) and emergency departments. The company’s proprietary platform, RADAR, acts as an AI video co-pilot for clinicians, integrating live video, vital signs, and Electronic Medical Records (EMRs) to intelligently interpret events in real-time and guide care […]

Exo Imaging is a pioneering healthcare AI company dedicated to modernizing medical imaging through its high-performance handheld ultrasound platform and artificial intelligence. The company’s mission is to make high-quality, affordable, and easy-to-use medical imaging accessible to healthcare professionals worldwide, enabling them to make critical, real-time decisions that ultimately improve patient outcomes. Exo’s technology combines advances […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.